📋 Tender Overview
Contract awarded for Framework agreement for oncological medicines 16 batches lot-0003, title: cabazitaxel conc. + sol. / sol. perf. 60 mg (1.5ml concentrate + 4.5ml solvent), description: cabazitaxel conc. + sol. / sol. perf. 60 mg (1.5ml concentrate + 4.5ml solvent) minimum quantity framework agreement 10 maximum quantity framework agreement 50 lot-0006, title: docetaxel conc. for sol. / perf. 20mg/ml - 4ml, description: docetaxel conc. for sol. / perf. 20mg/ml - 4ml minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0007, title: doxorubicin powder + mixture for conc. for disp. liposomal for perf. (bottle liposomal + bottle buffer solution) 50mg/bottle, description: doxorubicin powder + mixture for conc. for disp. liposomal for perf. (bottle liposomal + bottle buffer solution) 50mg/bottle minimum quantity framework agreement 20 maximum quantity framework agreement 200 lot-0008, title: trastuzumab powder for conc. for sol. perf. 150 mg, description: trastuzumab powder for conc. for sol. perf. 150 mg minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0011, title: cisplatin conc. for sol. / perf. 1 mg/ml -50 ml, description: cisplatin conc. for sol. / perf. 1 mg/ml -50 ml minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0013, title: fluorouracil / conc. for sol. inj. / perf. 50mg/ml-100 ml, description: fluorouracil / conc. for sol. inj. / perf. 50mg/ml-100 ml minimum quantity framework agreement 10 maximum quantity framework agreement 400 lot-0014, title: gemcitabine powder for sol. perf. 100mg/ml – 10 ml (1000 mg), description: gemcitabine powder for sol. perf. 100mg/ml – 10 ml (1000 mg) minimum quantity framework agreement 10 maximum quantity framework agreement 200 estimated value excluding vat: 11020.00 ron.Framework agreement for oncological medicines 16 batches